Akanda (AKAN) Non-Current Assets (2020 - 2025)
Akanda's (AKAN) quarterly Non-Current Assets came in at $2.6 million in Q4 2025, down 9.27% year-on-year from $2.9 million in Q4 2024, and down 2.05% quarter-over-quarter from $2.6 million in Q2 2025.
Akanda (AKAN) Non-Current Assets (2020 - 2025) Analysis & Trends
Akanda's Non-Current Assets history runs 6 years deep, the most recent figure standing at $2.6 million for Q4 2025.
- On a quarterly basis, Non-Current Assets fell 9.27% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $10.5 million, a 77.03% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 9.27% from the prior year.
- Non-Current Assets retreated to $2.6 million in Q4 2025 per AKAN's latest filing, from $2.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $36.5 million in Q2 2022 and bottomed at $2.4 million in Q2 2024.
- The 5-year median for Non-Current Assets is $4.1 million (2021), against an average of $14.1 million.
- Across the five-year window, Non-Current Assets jumped 765.18% in 2022 and tumbled 92.93% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $4.1 million in 2021, then jumped by 765.18% to $35.2 million in 2022, then tumbled by 80.0% to $7.0 million in 2023, then slumped by 59.36% to $2.9 million in 2024, then retreated by 9.27% to $2.6 million in 2025.
- Per Business Quant, the three latest AKAN Non-Current Assets figures stand at $2.6 million (Q4 2025), $2.6 million (Q2 2025), and $2.9 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.59 Mn |
| Jun 30, 2025 | 2.65 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Jun 30, 2024 | 2.35 Mn |
| Dec 31, 2023 | 7.03 Mn |
| Jun 30, 2023 | 33.26 Mn |
| Dec 31, 2022 | 35.18 Mn |
| Jun 30, 2022 | 36.54 Mn |
| Dec 31, 2021 | 4.07 Mn |
| Dec 31, 2020 | 4.15 Mn |